Skip to main content
. 2018 Jul 11;8(44):24932–24941. doi: 10.1039/c8ra03629b

Fig. 5. Significant changes in metabolite biomarker candidates in control and model groups. (A) Heatmap visualization for plasma samples from the control and model groups. (B) Unsupervised PCA analysis of different groups. (C) VIP scores of the metabolite marker candidates.

Fig. 5